← Open Payments lookup

AMY BOGGS: Open Payments

NPI 1629370291 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,146 in 181 payments from 17 companies in 2025. Trend: 2023 $3,805 · 2024 $2,958 · 2025 $3,146

Food & beverage: $3,146
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)36$536
Neurocrine BioSciences, Inc.18$353
Otsuka America Pharmaceutical, Inc.20$343
ABBVIE INC.31$341
Janssen Pharmaceuticals, Inc17$264
Alkermes, Inc.13$237
Teva Pharmaceuticals USA, Inc.8$178
Supernus Pharmaceuticals, Inc.4$175
E.R. Squibb & Sons, L.L.C.9$156
Takeda Pharmaceuticals U.S.A., Inc.7$138

Products named: CAPLYTA, INGREZZA, VRAYLAR, REXULTI, SPRAVATO, Qelbree, COBENFY, TRINTELLIX.

Industry payments across OK — which companies pay providers there.